8-37965728-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_000025.3(ADRB3):āc.742G>Cā(p.Glu248Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000904 in 1,549,418 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_000025.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ADRB3 | ENST00000345060.5 | c.742G>C | p.Glu248Gln | missense_variant | 1/2 | 1 | NM_000025.3 | ENSP00000343782.3 | ||
ENSG00000285880 | ENST00000647937.1 | c.226G>C | p.Glu76Gln | missense_variant | 1/2 | ENSP00000497740.1 | ||||
ADRB3 | ENST00000520341.2 | n.870G>C | non_coding_transcript_exon_variant | 1/1 | 6 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152166Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000188 AC: 28AN: 149178Hom.: 0 AF XY: 0.000266 AC XY: 21AN XY: 79008
GnomAD4 exome AF: 0.0000966 AC: 135AN: 1397134Hom.: 1 Cov.: 31 AF XY: 0.000144 AC XY: 99AN XY: 688820
GnomAD4 genome AF: 0.0000328 AC: 5AN: 152284Hom.: 0 Cov.: 33 AF XY: 0.0000403 AC XY: 3AN XY: 74476
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 15, 2021 | The c.742G>C (p.E248Q) alteration is located in exon 1 (coding exon 1) of the ADRB3 gene. This alteration results from a G to C substitution at nucleotide position 742, causing the glutamic acid (E) at amino acid position 248 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at